AU5597998A - Recombinant plague vaccine - Google Patents

Recombinant plague vaccine

Info

Publication number
AU5597998A
AU5597998A AU55979/98A AU5597998A AU5597998A AU 5597998 A AU5597998 A AU 5597998A AU 55979/98 A AU55979/98 A AU 55979/98A AU 5597998 A AU5597998 A AU 5597998A AU 5597998 A AU5597998 A AU 5597998A
Authority
AU
Australia
Prior art keywords
plague vaccine
recombinant plague
recombinant
vaccine
plague
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55979/98A
Inventor
Elizabeth J Haanes
Jorge E. Osorio
Rex E. Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heska Corp
Original Assignee
Heska Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heska Corp filed Critical Heska Corp
Publication of AU5597998A publication Critical patent/AU5597998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU55979/98A 1996-12-04 1997-12-04 Recombinant plague vaccine Abandoned AU5597998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76711596A 1996-12-04 1996-12-04
US08767115 1996-12-04
PCT/US1997/022617 WO1998024912A2 (en) 1996-12-04 1997-12-04 Recombinant plague vaccine

Publications (1)

Publication Number Publication Date
AU5597998A true AU5597998A (en) 1998-06-29

Family

ID=25078527

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55979/98A Abandoned AU5597998A (en) 1996-12-04 1997-12-04 Recombinant plague vaccine

Country Status (2)

Country Link
AU (1) AU5597998A (en)
WO (1) WO1998024912A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003502010A (en) * 1998-11-18 2003-01-21 インナチュレ リミテッド Product
US7344718B2 (en) 2003-01-31 2008-03-18 University Of North Dakota Yersinia species compositions
WO2006079076A2 (en) 2005-01-21 2006-07-27 Epitopix, Llc Yersinia spp. polypeptides and methods of use
CA2960659C (en) 2007-11-09 2021-07-13 The Salk Institute For Biological Studies Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
US9211327B2 (en) 2011-06-22 2015-12-15 University Of North Dakota Use of YSCF, truncated YSCF and YSCF homologs as adjuvants
US9328149B2 (en) 2013-07-12 2016-05-03 The Catholic University Of America Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines
CN114560932B (en) * 2022-02-18 2023-09-12 中国人民解放军军事科学院军事医学研究院 Plague neutralizing antibody and application thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266313A (en) * 1987-02-03 1993-11-30 The United States Of America As Represented By The Department Of Health And Human Services Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms
AU626288B2 (en) * 1988-02-05 1992-07-30 Commonwealth Scientific And Industrial Research Organisation Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence
CA1339307C (en) * 1988-09-06 1997-08-19 Roy Curtiss, Iii Oral immunization by transgenic plants
AU2347692A (en) * 1991-07-09 1993-02-11 Cornell Research Foundation Inc. Recombinant viral vaccine
AU2699192A (en) * 1991-10-16 1993-05-21 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
ES2249760T3 (en) * 1993-01-26 2006-04-01 The Trustees Of The University Of Pennsylvania (A Corporation Of Pennsylvania) COMPOSITIONS AND PROCEDURES OF ADMINISTRATION OF GENETIC MATTERS.
WO1994024296A2 (en) * 1993-04-19 1994-10-27 University Of Saskatchewan Recombinant bovine herpesvirus type 1 vaccines
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
GB9326425D0 (en) * 1993-12-24 1994-02-23 Secr Defence Vaccine compositions
US6630455B1 (en) * 1995-01-13 2003-10-07 Vanderbilt University Methods for inducing mucosal immune responses
CN1155707C (en) * 1995-03-13 2004-06-30 英国国防部 Vaccines for plague

Also Published As

Publication number Publication date
WO1998024912A2 (en) 1998-06-11
WO1998024912A3 (en) 1998-09-11

Similar Documents

Publication Publication Date Title
AU4781297A (en) Vaccines
AUPO203996A0 (en) Therapeutic uses
AU7645496A (en) Roundsling construction
AU4922497A (en) Interleukin-18-receptor proteins
AU6721696A (en) Cd44-like protein
AUPO062596A0 (en) Improved mausoleum
AUPN765396A0 (en) Crypt system
AUPO434196A0 (en) An improved therapeutic
AU4646097A (en) Improved multiple-burst-correction system
AUPO026596A0 (en) Viral peptide
AU5597998A (en) Recombinant plague vaccine
AU6715094A (en) Recombinant vaccine
AU3552797A (en) Vaccine preparations
AUPO039696A0 (en) Improved anchoring system
AU4582597A (en) Therapeutic proteins
AU2904497A (en) Shelter
AU2232399A (en) Recombinant ctb-based vaccines
EP0904287A3 (en) Cytokine designated lerk-8
AU3894497A (en) Novel human glycoprotein
AU7081896A (en) Rabies recombinant adenovirus
AUPO168996A0 (en) Structure
AU5137598A (en) Novel protein
AU1317797A (en) Video analyzer-tester
AU5369296A (en) Human cytokine polypeptide
AUPN758496A0 (en) Calcination